Table of Contents Table of Contents
Previous Page  782-783 / 2605 Next Page
Information
Show Menu
Previous Page 782-783 / 2605 Next Page
Page Background

‹#›

Rationale for proton therapy in combined

modality therapy for NSCLC: reduced toxicity

1 … 772-773 774-775 776-777 778-779 780-781 782-783 784-785 786-787 788-789 790-791 792-793 794-795 … 2604-2605  FlippingBook